Security key
608550208
Molecular Templates, Inc. - Common Stock (MTEM)
CUSIP: 608550208
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 475
- Total 13F value
- $668
- Share change
- +475
- SEC-reported price per share
- $1.41
- Number of holders
- 1
- Value change
- +$668
- Number of buys
- 1
Report period
Q3 2025
Institutions
1
Top holders
0
MTEM full security history
Ownership snapshot
Newer quarter: Q4 2025
Molecular Templates, Inc. SEC filings
Molecular Templates, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 608550208
Recent filing periods:
Ownership snapshot
Top reported holders of MTEM - Molecular Templates, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SHV Management Services, LLC
Disclosed value leader
SHV Management Services, LLC
Comparable rows
0/15
Latest evidence
14 Nov 2024
3/4/5
Highest disclosed value: $3,399,963
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
SHV Management Services, LLC has the largest disclosed position value at $3.4M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SHV Management Services, LLC's linked filing trail.
Disclosed position value
Top 4
SHV Management Services, LLC
$3.4M
Kevin M. Lalande
$2.49M
BIOTECH TARGET N V
$412.5K
Sean McLennan
$14.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SHV Management Services, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$3,399,963
7,233,963 shares
|
— | 13 Jun 2022 |
| Kevin M. Lalande |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$2,489,047
2,214,494 shares
mixed-class rows
|
— | 27 Sep 2024 |
| BIOTECH TARGET N V |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$412,500
904,001 shares
mixed-class rows
|
— | 14 Nov 2024 |
| Sean McLennan |
3/4/5
Chief Financial Officer (interim) and Treasurer
|
—
class O/S missing
|
$14,100
30,000 shares
|
— | 16 Jun 2022 |
| Roger J. Waltzman |
3/4/5
Chief Medical Officer
|
—
class O/S missing
|
—
170,000 shares
|
— | 15 Feb 2023 |
| Eric E. Poma |
3/4/5
Chief Executive Officer and Chief Scientific Officer, Director
|
—
class O/S missing
|
—
23,333 shares
|
— | 23 Jan 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Archived quarter
Historical 13F summary for Q3 2025
This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.